Novo chair re-elected despite dual role criticism
Lars Rebien Sørensen has been re-elected as Chairman of the Board at Novo Nordisk for a one-year term. During the annual general meeting, three new members were elected, including Genmab CEO Jan van de Winkel, while Mars CEO Poul Weihrauch joined as an observer to provide a consumer-oriented focus. Sørensen faced criticism for his dual […]